Learn more

INST NAT SANTE RECH MED

Overview
  • Total Patents
    5,625
  • GoodIP Patent Rank
    910
  • Filing trend
    ⇧ 15.0%
About

INST NAT SANTE RECH MED has a total of 5,625 patent applications. It increased the IP activity by 15.0%. Its first patent ever was published in 1969. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are US GOV HEALTH & HUMAN SERV, ONCOTHERAPY SCIENCE LTD and ONCOTHERAPY SCIENCE INC.

Patent filings per year

Chart showing INST NAT SANTE RECH MEDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bensussan Armand 75
#2 Schwartz Jean-Charles 68
#3 Fournie-Zaluski Marie-Claude 58
#4 Tedgui Alain 57
#5 Mallat Ziad 55
#6 Olive Daniel 50
#7 Roques Bernard Pierre 40
#8 Chambon Pierre 39
#9 Bonneville Marc 38
#10 Nassif Xavier 37

Latest patents

Publication Filing date Title
US2021069313A1 Vaccination against diabetes, obesity and complications thereof
WO2021074392A1 Visual detection of pbd induced dna crosslinks
WO2021074408A1 Method for controlling the access to a computer platform and associated devices
WO2021074391A1 Methods for diagnosing nasal intestinal type adenocarcinomas
WO2021074338A1 Methods of determining whether patients suffering from acute myeloid leukemia will achieve a response to an myc-targeting therapy
WO2021069654A1 Antisense oligonucleotides and their use for the treatment of pain
WO2021069593A1 T cells modified to express mutated cxcr4 or partially deleted and uses thereof
WO2021064186A1 Novel pyridin-2(1h)one derivatives, their preparation and their use for the treatment of pain
WO2021064184A1 Methods and pharmaceutical composition for the treatment of ovarian cancer, breast cancer or pancreatic cancer
WO2021064180A1 Methods and compositions for modulating macrophages polarization
WO2021064069A1 Methods for the treatment of adult t-cell leukemia/lymphoma
WO2021064072A1 Use of retinoic acid receptor (rar) agonists for reversing, preventing, or delaying calcification of aortic valve
WO2021063968A1 Method and composition for diagnosing chronic obstructive pulmonary disease
WO2021058763A1 Anti-müllerian inhibiting substance antibodies and uses thereof
WO2021058729A1 Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof
WO2021058744A1 Use of müllerian inhibiting substance inhibitors for treating cancer
WO2021058731A1 A method for measuring the speed of sound in liver with a specific probe and associated methods and devices
WO2021058732A1 A method for measuring the speed of sound in liver with a moving probe and associated methods and devices
WO2021058597A1 Methods of determining whether a subject is at risk of developing arterial plaques
WO2021048292A1 Methods and compositions for treating melanoma